Overview Safety & Efficacy WC3011 in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women Status: Completed Trial end date: 2012-02-01 Target enrollment: Participant gender: Summary Study if WC3011 is effective and safe in the treatment of postmenopausal vaginal dryness due to vulvovaginal atrophy. Phase: Phase 3 Details Lead Sponsor: Warner Chilcott